PROGNOSTIC STAGE IIIC BREAST CANCER AJCC V8
Clinical trials for PROGNOSTIC STAGE IIIC BREAST CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new PROGNOSTIC STAGE IIIC BREAST CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for PROGNOSTIC STAGE IIIC BREAST CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo for aggressive breast cancer falls short in early trial
Disease control TerminatedThis study tested a two-drug combination (nab-paclitaxel and alpelisib) given before surgery to people with a hard-to-treat type of breast cancer called triple-negative breast cancer that also had specific genetic changes (PIK3CA or PTEN). The goal was to see if the drugs could s…
Matched conditions: PROGNOSTIC STAGE IIIC BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 03:28 UTC
-
New hope for chemo-resistant breast cancer? trial tests targeted pill
Disease control TerminatedThis study tested a drug called abemaciclib in people with triple negative breast cancer that did not shrink with standard chemotherapy. The goal was to see if the drug could change the immune environment inside the tumor, making it more responsive. The trial was stopped early, b…
Matched conditions: PROGNOSTIC STAGE IIIC BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 11, 2026 20:41 UTC
-
New program aims to boost Well-Being in young black breast cancer survivors
Symptom relief TerminatedThis study tested a program to improve quality of life for young African American women who finished treatment for early- or late-stage breast cancer. About 27 women took part in either the program or a comparison group. The goal was to see if the program helped with physical, me…
Matched conditions: PROGNOSTIC STAGE IIIC BREAST CANCER AJCC V8
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated May 17, 2026 03:30 UTC
-
New phone program aims to ease daily struggles for young black breast cancer patients
Symptom relief TerminatedThis study tested a four-month telephone program called Y-AMBIENT designed to help young African American women (ages 18-44) with stage I-III breast cancer manage daily life during chemotherapy or radiation. The program included educational sessions, follow-up calls, and videos. …
Matched conditions: PROGNOSTIC STAGE IIIC BREAST CANCER AJCC V8
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated May 17, 2026 03:24 UTC
-
Can a gut pill stop chemo stomach woes? trial tests rifaximin for breast cancer patients
Symptom relief TerminatedThis study tested the antibiotic rifaximin in 20 people with early-stage HER2-positive breast cancer who had stomach problems from pertuzumab-based chemotherapy. The goal was to see if rifaximin could reduce side effects like diarrhea and belly pain, helping patients stay on thei…
Matched conditions: PROGNOSTIC STAGE IIIC BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 17, 2026 03:23 UTC